Johnson Pharmacare Limited submitted a formal undertaking to BSE Limited regarding compliance with SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015.
The document specifically addresses Regulation 32, which requires listed entities to submit statements indicating:
- Deviations in the use of proceeds from objects stated in offer documents
- Category-wise variations between projected and actual utilization of funds (capital expenditure, sales and marketing, working capital, etc.)
Mr. Nand Kishor Ray, Additional Director (DIN: 11626638) of Johnson Pharmacare Limited, certified that compliance with Regulation 32 is not applicable to the company for the quarter and financial year ended March 31, 2026. The basis for this non-applicability is that the company has not issued any shares by way of public issue, rights issue, preferential issue, or similar methods during this period.
The company requested BSE to take this undertaking on record and acknowledge the same.
Financial Impact
No financial impact disclosed. The filing is a regulatory compliance statement regarding non-applicability of specific disclosure requirements.